BTG (BTGGF) FCF Yield % : 2.78 (As of Apr. 27, 2024)

View and export this data going back to . Start your Free Trial

What is BTG FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, BTG's Trailing 12-Month Free Cash Flow is $0.0 Mil, and Market Cap is $20,315.6 Mil. Therefore, BTG's FCF Yield % for today is 2.78%.

The historical rank and industry rank for BTG's FCF Yield % or its related term are showing as below:

BTGGF' s FCF Yield % Range Over the Past 10 Years
Min: 1.09 Med: 2.65 Max: 5.38
Current: 2.78

During the past 13 years, the highest FCF Yield % of BTG was 5.38%. The lowest was 1.09%. And the median was 2.65%.

BTGGF's FCF Yield % is not ranked
in the Biotechnology industry.
Industry Median: -15.535 vs BTGGF: 2.78

BTG's FCF Margin % for the quarter that ended in Mar. 2019 was 18.00%.

BTG FCF Yield % Historical Data

The historical data trend for BTG's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BTG FCF Yield % Chart

BTG Annual Data

Trend

Mar10

Mar11

Mar12

Mar13

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

FCF Yield %

Get a 7-Day Free Trial

1.33

2.72

2.88

3.84

2.68

BTG Semi-Annual Data
	Sep09	Mar10	Sep10	Mar11	Sep11	Mar12	Sep12	Mar13	Sep13	Mar14	Sep14	Mar15	Sep15	Mar16	Sep16	Mar17	Sep17	Mar18	Sep18	Mar19
FCF Yield %	Get a 7-Day Free Trial															0.58	5.50	2.45	2.62	3.59

Competitive Comparison of BTG's FCF Yield %

For the Biotechnology subindustry, BTG's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

BTG's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, BTG's FCF Yield % distribution charts can be found below:

* The bar in red indicates where BTG's FCF Yield % falls into.

BTG FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

BTG's FCF Yield % for the fiscal year that ended in Mar. 2019 is calculated as

FCF Yield %	=	Free Cash Flow	/	Market Cap
	=	112.5	/	4197.71412
	=	2.68%

BTG's annualized FCF Yield % for the quarter that ended in Mar. 2019 is calculated as

FCF Yield %	=	Free Cash Flow	*	Annualized Factor	/	Market Cap
	=	75.3	*	2	/	4197.71412
	=	3.59%

BTG FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

BTG FCF Yield % Related Terms

Thank you for viewing the detailed overview of BTG's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

BTG (BTGGF) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BTG PLC (OTCPK:BTGGF) » Definitions » FCF Yield %

Comparable Companies

Traded in Other Exchanges

N/A

Address

5 Fleet Place, London, GBR, EC4M 7RD

Website

http://www.btgplc.com

BTG is a biotechnology company that develops products in specialty areas of medicine. The company's three operating segments are interventional medicine, specialty pharmaceuticals, and licensing. Its interventional medicine focuses on oncology, vascular treatments, and pulmonology. BTG's revenue is roughly split between these three segments, while its oncology operations lead the interventional segment. The company has been known to utilize acquisitions for investing in leading therapies and capabilities.